BABA vs CUE · P/E 20, rev $137.30B vs rev $9.3M
Alibaba Group Holding Ltd (BABA) versus Cue Biopharma (CUE) — a side-by-side from cached financials, not a winner call.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
BABA currently screens at market cap $305.19B and trailing P/E 19.6. CUE currently screens at market cap $59.5M.
Not investment advice. Open the BABA and CUE stock pages for the full models.
Not investment advice.